Department of Ophthalmology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Department of Neonatology, Newborn Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Doc Ophthalmol. 2022 Dec;145(3):175-184. doi: 10.1007/s10633-022-09889-5. Epub 2022 Oct 6.
To develop and validate a flicker electroretinogram (ERG) protocol in term-born neonates as a potential tool for assessing preterm infants at risk of developing retinopathy of prematurity.
A custom flicker ERG protocol was developed for use with the hand-held RETeval® electrophysiology device. Feasibility of measuring flicker ERG through closed eyelids and without mydriasis was established in a pilot study enabling optimisation of the test protocol. Following this, healthy term-born neonates (gestational age 37-42 weeks) were recruited at the Neonatology clinic of the University Hospital Zurich. Flicker ERG recordings were performed using proprietary disposable skin electrodes during the first four days of life when the infants were sleeping. Flicker stimuli were presented at 28.3 Hz for a stimulus series at 3, 6, 12, 30, and 50 cd·s/m, with two measurements at each stimulus level. Results were analysed offline. Flicker ERG peak times and amplitudes were derived from the averaged measurements per stimulus level for each subject.
28 term-born neonates were included in the analysis. All infants tolerated the testing procedure well. Flicker ERG recording was achieved in all subjects with reproducible flicker ERG waveforms for 30 and 50 cd·s/m stimuli. Reproducible ERGs were recorded in the majority of infants for the weaker stimuli (with detectable ERGs in 20/28, 25/28, and 27/28 at 3, 6, and 12 cd·s/m, respectively). Flicker ERG amplitudes increased with increasing stimulus strength, with peak times concurrently decreasing slightly.
Flicker ERG recording is feasible and reliably recorded in sleeping neonates through closed eyelids using skin electrodes and without mydriasis. Flicker ERG amplitude decreases for lower luminance flicker but remains detectable for 3 cd·s/m flicker in the majority of healthy term-born neonates. These data provide a basis to study retinal function in premature infants using this protocol.
开发并验证一种用于足月新生儿的闪烁视网膜电图(ERG)方案,作为评估有发生早产儿视网膜病变风险的早产儿的潜在工具。
为使用手持式 RETeval®电生理设备,开发了一种定制的闪烁 ERG 方案。通过在试点研究中测量闭眼和不散瞳的闪烁 ERG,确定了通过闭合的眼睑和不散瞳来测量闪烁 ERG 的可行性,从而优化了测试方案。在此之后,在苏黎世大学医院的新生儿科诊所招募了健康的足月新生儿(胎龄 37-42 周)。在新生儿生命的头四天,当婴儿睡觉时,使用专有一次性皮肤电极进行闪烁 ERG 记录。闪烁刺激以 28.3 Hz 的频率呈现,刺激系列为 3、6、12、30 和 50 cd·s/m,每个刺激水平有两次测量。结果进行离线分析。从每个刺激水平的每个受试者的平均测量值中得出闪烁 ERG 的峰时间和幅度。
28 名足月新生儿纳入分析。所有婴儿均能很好地耐受测试过程。所有受试者均成功进行了闪烁 ERG 记录,对于 30 和 50 cd·s/m 的刺激,可获得可重复的闪烁 ERG 波形。对于较弱的刺激,大多数婴儿可记录到可重复的 ERG(分别在 3、6 和 12 cd·s/m 时,有 20/28、25/28 和 27/28 个可检测到 ERG)。随着刺激强度的增加,闪烁 ERG 幅度增加,同时峰时间略有下降。
通过使用皮肤电极和不散瞳闭合眼睑,在睡眠中的新生儿中进行闪烁 ERG 记录是可行的,并且可可靠地记录。对于较低亮度的闪烁,闪烁 ERG 幅度降低,但在大多数健康的足月新生儿中,仍可检测到 3 cd·s/m 的闪烁。这些数据为使用该方案研究早产儿的视网膜功能提供了基础。